中航成飛(302132.SZ): 本次美國關稅政策對公司正常生產經營無影響
格隆匯4月8日丨中航成飛(302132.SZ)在投資者互動平臺表示,中航成飛作爲國內航空整機裝備研製生產重點骨幹企業,堅持科技自立自強,以科技創新引領企業高質量發展,通過多年的創新發展,公司主要產品供應鏈爲全國產化,當前,公司產業鏈供應鏈穩定暢通。 本次美國關稅政策對公司正常生產經營無影響,對上市公司經營無實質影響。經濟全球化是社會生產力發展的客觀要求和科技進步的必然結果,公司將密切關注國際環境變化,持續加大軍貿業務開拓的力度和廣度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.